Andrei Doroshin is a former graduate student and was CEO of a now-disbanded vaccine distribution group. He is noted for being the CEO of Philly Fighting COVID, a controversial nonprofit organization in Philadelphia, that played a role in the city's COVID-19 response before its relationship with the city was terminated due in part to questions about Doroshin's qualifications, the organization's plans to transition to a for-profit model, and its handling of citizens' data.
Career
Most notably, Doroshin was the CEO of the Philadelphia non-profit Philly Fighting Covid that manufactured over 5,000 face shields, tested over 21,000 people, and vaccinated over 6,800 people before the city terminated the relationship due to a number of controversies. Philadelphia's NPR affiliate, WHYY, describes its 6-part series devoted to the scandal as "the story of a 22-year-old with no health care experience who talked his way into a COVID-19 vaccine distribution deal he thought would make him millions."
Philly Fighting Covid (PFC)
Founding and face shields
In March 2020, Doroshin founded a non-profit corporation named Philly Fighting Covid in response to the COVID-19 pandemic. The organization first created face-shields during the global PPE shortage. Doroshin brought together a team of engineers, operations personnel, supply chain experts, and volunteers to build a sustained face shield manufacturing operation. Doroshin oversaw the creation of a research and design facility, manufacturing facility, and a decontamination and packaging facility. In total, Philly Fighting Covid manufactured, cleaned, packaged, and delivered over 5,000 face shields.
COVID-19 testing
In June 2020, it opened the first testing site in Philadelphia that did not require a doctor's note, patient symptoms, or insurance/payment. Initially, Philly Fighting Covid (PFC) was doing 300 tests a week and operated solely with personal and donor funds.
In July 2020, PFC partnered with the Philadelphia Department of Public Health and received funding ($194,234) to conduct COVID-19 testing. With this support from the city, PFC tested over 1,000 patients per week. The contract did not specify specific testing locations but PFC represented that the organization would focus on underserved communities and frontline healthworkers.
COVID-19 vaccinations
On December 24, 2020, Doroshin was approved by the Philadelphia Department of Public Health to open a mass COVID-19 vaccine site on January 8, 2021. Doroshin hired cybersecurity experts, software engineers, medical operations staff, process engineers, and contracted with PREPMOD (a software recommended by the CDC) to ensure that our data systems would be operational. Doroshin hired over 20 registered nurses, 20 providers (nurse practitioners, pharmacist, MD, DO, or PA) and brought on over 30 nursing students to run the clinic. Working closely with the Philadelphia Department of Public Health, the clinic was opened for healthcare workers in Philadelphia. Doroshin's team vaccinated over 6,800 vaccines in five days of operation. After alerts from the media, the Health Commissioner reviewed Philly Fighting COVID's data policy and raised concerns that it allowed the organization to sell data collected from members of the public.